{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:14:25Z","timestamp":1761167665010,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ghir.2009.05.003","type":"journal-article","created":{"date-parts":[[2009,6,27]],"date-time":"2009-06-27T04:57:52Z","timestamp":1246078672000},"page":"513-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of IGF-2\/ApaI polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs"],"prefix":"10.1016","volume":"19","author":[{"given":"Alessandra C.","family":"Marcolin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana M.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francielle M.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"El Beitune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla V.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester S.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2009.05.003_bib1","unstructured":"World Health Organization, HIV\/AIDS Programme, Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards Universal Access, Recommendations for a Public Health Approach, WHO, 2006, available from: <www.who.int\/hiv\/pub\/guidelines\/pmtctguidelines3.pdf>."},{"key":"10.1016\/j.ghir.2009.05.003_bib2","doi-asserted-by":"crossref","unstructured":"The Working Group on Mother-To-Child Transmission of HIV, Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8 (1995) 506\u2013510.","DOI":"10.1097\/00042560-199504120-00011"},{"key":"10.1016\/j.ghir.2009.05.003_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","volume":"40","author":"European Collaborative Group, Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ghir.2009.05.003_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy","volume":"38","author":"Tuomala","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ghir.2009.05.003_bib5","unstructured":"Centers for disease control and prevention, public health service task force, recommendations for use of antiretroviral drugs in pregnant HIV-1-Infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States, 2008, pp. 1\u201398. available from: <http:\/\/aidsinfo.nih.gov\/contentfiles\/PerinatalGL.pdf>."},{"key":"10.1016\/j.ghir.2009.05.003_bib6","first-page":"797","article-title":"Human immunodeficiency virus infection in pregnancy","volume":"101","author":"Minkoff","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2009.05.003_bib7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/01.AOG.0000265211.76196.ac","article-title":"Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites","volume":"109","author":"Read","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2009.05.003_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAI.0b013e318031d5a0","article-title":"Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 infection (AIDS Clinical Trials Group Study A5095)","volume":"44","author":"Shikuma","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ghir.2009.05.003_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2009.05.003_bib10","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ghir.2009.05.003_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/dmrr.576","article-title":"Effect of antiretroviral agents on carbohydrate metabolism in HIV-1 infected pregnant women","volume":"22","author":"El Beitune","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ghir.2009.05.003_bib12","first-page":"369","article-title":"Effects of antiretroviral drugs on glucide metabolism and pancreatic Langerhans\u2019 cells of pregnant Wistar rats","volume":"26","author":"Figueiro-Filho","year":"2004","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.ghir.2009.05.003_bib13","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s001250100034","article-title":"Insulin-like growth factor 2 (IGF2) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes","volume":"44","author":"Ukkola","year":"2001","journal-title":"Diabetologia"},{"issue":"S1","key":"10.1016\/j.ghir.2009.05.003_bib14","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.2337\/diabetes.53.2007.S26","article-title":"Genetic factors and insulin secretion: gene variants in the IGF genes","volume":"53","author":"\u2018T Hart","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2009.05.003_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.ijo.0800483","article-title":"ApaI polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males","volume":"21","author":"O\u2019Dell","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ghir.2009.05.003_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ghir.2005.06.016","article-title":"Association between birth weight, body mass index and IGF2\/ApaI polymorphism","volume":"15","author":"Gomes","year":"2005","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2009.05.003_bib17","first-page":"1117","volume":"99","author":"Perinatal HIV Guidelines Working Group, Summary of the updated recommendations from the Public Health Service Task Force to reduce perinatal human immunodeficiency virus-1 transmission in the United States","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2009.05.003_bib18","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1093\/nar\/19.24.6967","article-title":"Polymerase chain reaction (PCR) for detection of ApaI polymorphism at the insulin like growth factor II gene (IGF2)","volume":"19","author":"Tadokoro","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"S1","key":"10.1016\/j.ghir.2009.05.003_bib19","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2337\/diacare.28.suppl_1.S37","volume":"28","author":"American Diabetes Association, Diagnosis and Classification of Diabetes Mellitus","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2009.05.003_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1043-2760(00)00305-2","article-title":"Life and death of the pancreatic beta cells","volume":"11","author":"Bonner-Weir","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2009.05.003_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1054\/ghir.2002.0265","article-title":"Signaling through IGF-I and insulin receptors: where is the specificity?","volume":"12","author":"Kim","year":"2002","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2009.05.003_bib22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/ajcn\/71.5.1256s","article-title":"Carbohydrate and lipid metabolism in pregnancy; normal compared with gestational diabetes mellitus","volume":"7","author":"Butte","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2009.05.003_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.ejhg.5200381","article-title":"Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity","volume":"7","author":"O\u2019Dell","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ghir.2009.05.003_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2005.07.028","article-title":"The role of the insulin-like growth factor system in prenatal growth","volume":"86","author":"Randhawa","year":"2005","journal-title":"Mol. Genet. Metab."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637409000823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637409000823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:45:08Z","timestamp":1761086708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637409000823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1096637409000823"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2009.05.003","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of IGF-2\/ApaI polymorphism in pregnant women infected with human immunodeficiency virus type 1 taking antiretroviral drugs","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2009.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}